Orphanet: Pesquisa simples
x

Pesquisar um ensaio clínico

* (*) campo(s) de preenchimento obrigatório

125 Resultado(s)

Ordenados por

Ensaio em fase de recrutamento = Ensaio em fase de recrutamento; Ensaio a decorrer = Ensaio a decorrer; Financiado por um membro do IRDiRC = ; Membro de uma ERN =

Ensaio (s) clínico (s) nacional (is)

ALEMANHA

Sachsen
LEIPZIG

ALEMANHA

Baden-Württemberg
FREIBURG

ALEMANHA

Baden-Württemberg
HEIDELBERG

ALEMANHA

Baden-Württemberg
TÜBINGEN

Ensaio em fase de recrutamentoEnsaio a decorrerCD3/CD19 Haplo (E410/2007): Multicenter phase II study of Haploidentical Hematopoietic Cell Transplantation with CD3/CD19 depleted Grafts after a reduced intensity conditioning regimen for adult Patients with Acute Leukemia
Department für Innere Medizin - Medizinische Universitätsklinik Tübingen
Innere Medizin II - Onkologie, Hämatologie, Klinische Immunologie, Rheumatologie und Pulmologie

ALEMANHA

Bayern
MÜNCHEN

ALEMANHA

Bayern
REGENSBURG

Ensaio em fase de recrutamentoEnsaio a decorrerINFORM2 NivEnt: exploratory multinational phase I/II combination study of Nivolumab and Entinostat in children and adolescents with refractory high-risk malignancies
Universitätsklinikum Regensburg
Abteilung für Pädiatrische Hämatologie, Onkologie und Stammzelltransplantation

ALEMANHA

Berlin
ADDRESS: NOT PROVIDED - DE

ALEMANHA

Hessen
FRANKFURT AM MAIN

Ensaio em fase de recrutamentoEnsaio a decorrerPANOBEST: Phase I/II study with oral panobinostat maintenance therapy following allogeneic stem cell transplantation in patients with high risk Myelodysplastic Syndrome (MDS) or Acute Myeloid Leukemia (AML)
Klinikum der Johann Wolfgang Goethe-Universität Frankfurt
Medizinische Klinik II - Hämatologie, Onkologie, Hämostaseologie, Rheumatologie, Infektiologie

ALEMANHA

Niedersachsen
HANNOVER

ALEMANHA

Nordrhein-Westfalen
ESSEN

Ensaio em fase de recrutamentoEnsaio a decorrerINFORM2 NivEnt: exploratory multinational phase I/II combination study of Nivolumab and Entinostat in children and adolescents with refractory high-risk malignancies
Universitätsklinikum Essen
Klinik für Kinderheilkunde III - Abteilung für pädiatrische Hämatologie und Onkologie

ALEMANHA

Sachsen
LEIPZIG

Ensaio em fase de recrutamentoEnsaio a decorrerBERGAMO: A Phase II Study Evaluating the Efficacy and Safety of Bemcentinib in Patients With Myelodysplastic Syndromes Failing Standard of Care Therapy -DE
Universitätsklinikum Leipzig AöR
Klinik und Poliklinik für Hämatologie, Zelltherapie und Hämostaseologie

ALEMANHA

Thüringen
JENA

Ensaio a decorrerMidostaurin in MRD (Minimal Residual Disease) Positive Acute Myeloid Leukemia After Allogeneic Stem Cell Transplantation
Universitätsklinikum Jena
Klinik für Innere Medizin II - Abteilung Hämatologie und Internistische Onkologie

ESPANHA

Madrid
MADRID

FRANCA

AUVERGNE-RHONE-ALPES
ADDRESS: NOT PROVIDED - FR

FRANCA

ILE-DE-FRANCE
LE CHESNAY

FRANCA

ILE-DE-FRANCE
PARIS

Ensaio em fase de recrutamentoEnsaio a decorrerA phase II study of the efficacy and safety of lenalidomide combined to azacitidine in intermediate-2 or high risk MDS AND AML with del 5q (GFM-Aza-Rev-09)
CHU Paris-GH St-Louis Lariboisière F.Widal - Hôpital Saint-Louis
Groupe Francophone des Myélodysplasies (GFM)

FRANCA

ILE-DE-FRANCE
PARIS

FRANCA

PROVENCE-ALPES-COTE D'AZUR
MARSEILLE

ITALIA

FRIULI VENEZIA GIULIA
UDINE

ITALIA

LAZIO
ROMA

Ensaio em fase de recrutamentoEnsaio a decorrerStudy protocol for acute myeloid leukemia in children and adolescent
IRCCS Ospedale Pediatrico Bambino Gesù - SEDE GIANICOLO
U.O. di Onco-Ematologia

ITALIA

LAZIO
ROMA

REINO UNIDO

South Glamorgan
CARDIFF

Ensaio a decorrerAML 16: A Programme of Treatment Development for Older Patients With Acute Myeloid Leukemia and High Risk Myelodysplastic Syndrome (PhaseII/III)
Cardiff University School of Medicine
Department of Medical Genetics, Haematology & Pathology

REINO UNIDO

South Glamorgan
CARDIFF

Ensaio em fase de recrutamentoEnsaio a decorrerAML 17: Randomised, controlled, open label, multi-arm trial looking at treatment for acute promyelocytic leukaemia (Phase III)
Cardiff University School of Medicine
Department of Medical Genetics, Haematology & Pathology

BELGICA

ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS

Ensaio a decorrerSTEP: Sorafenib Long Term Extension Program - BE
Cliniques universitaires Saint-Luc - UCLouvain
Pneumologie_Oncologie thoracique

Ensaio (s) clínico (s) multinacional (ais)

ALEMANHA

Hamburg
HAMBURG

ALEMANHA

Sachsen
LEIPZIG

BERGAMO: A Phase II Study Evaluating the Efficacy and Safety of Bemcentinib in Patients With Myelodysplastic Syndromes Failing Standard of Care Therapy
Universitätsklinikum Leipzig AöR
Klinik und Poliklinik für Hämatologie, Zelltherapie und Hämostaseologie

ESTADOS UNIDOS

New Jersey
RARITAN